(MHK) Mohawk Industries - Overview
Stock: Ceramic, Porcelain, Stone, Laminate, Vinyl
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 37.6% |
| Relative Tail Risk | -13.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.28 |
| Alpha | -7.42 |
| Character TTM | |
|---|---|
| Beta | 1.080 |
| Beta Downside | 0.901 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.77% |
| CAGR/Max DD | 0.11 |
Description: MHK Mohawk Industries January 08, 2026
Mohawk Industries (NYSE:MHK) is a global flooring manufacturer that designs, produces, sources, distributes, and markets a broad portfolio of residential and commercial flooring solutions-including ceramic, porcelain, natural stone, carpet, laminate, vinyl, and wood products-across North America, Europe, Latin America, and other international markets. The firm operates through three segments: Global Ceramic, Flooring North America, and Flooring Rest of the World, and leverages a diverse brand slate (e.g., Daltile, Quick-Step, Pergo) to serve home-center chains, specialty retailers, e-commerce platforms, builders, and commercial contractors.
Key performance indicators as of FY 2024 show $11.2 billion in revenue, a 5.8 % operating margin, and a 7 % year-over-year increase in net income, driven largely by strong demand in the U.S. remodeling market and a favorable shift toward resilient flooring (vinyl and luxury vinyl tile) that benefits from higher price points and lower raw-material volatility. The sector remains sensitive to housing-starts data, construction-material cost inflation, and macro-economic trends such as consumer confidence and interest-rate movements, which together set the near-term growth ceiling for Mohawk’s North American segment.
For a deeper dive into MHK’s valuation metrics and scenario analysis, consult the detailed research on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 421.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 0.60 > 1.0 |
| NWC/Revenue: 31.08% < 20% (prev 26.36%; Δ 4.72% < -1%) |
| CFO/TA 0.07 > 3% & CFO 993.6m > Net Income 421.1m |
| Net Debt (1.82b) to EBITDA (1.17b): 1.55 < 3 |
| Current Ratio: 2.25 > 1.5 & < 3 |
| Outstanding Shares: last quarter (62.6m) vs 12m ago -1.26% < -2% |
| Gross Margin: 24.01% > 18% (prev 0.25%; Δ 2376 % > 0.5%) |
| Asset Turnover: 79.62% > 50% (prev 81.21%; Δ -1.59% > 0%) |
| Interest Coverage Ratio: 20.40 > 6 (EBITDA TTM 1.17b / Interest Expense TTM 26.5m) |
Altman Z'' 4.99
| A: 0.24 (Total Current Assets 6.01b - Total Current Liabilities 2.67b) / Total Assets 13.62b |
| B: 0.55 (Retained Earnings 7.54b / Total Assets 13.62b) |
| C: 0.04 (EBIT TTM 540.7m / Avg Total Assets 13.47b) |
| D: 1.24 (Book Value of Equity 6.57b / Total Liabilities 5.28b) |
| Altman-Z'' Score: 4.99 = AAA |
Beneish M -2.96
| DSRI: 1.11 (Receivables 2.25b/2.04b, Revenue 10.72b/10.81b) |
| GMI: 1.04 (GM 24.01% / 25.05%) |
| AQI: 0.97 (AQ_t 0.19 / AQ_t-1 0.19) |
| SGI: 0.99 (Revenue 10.72b / 10.81b) |
| TATA: -0.04 (NI 421.1m - CFO 993.6m) / TA 13.62b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of MHK shares?
Over the past week, the price has changed by +11.41%, over one month by +17.62%, over three months by +23.40% and over the past year by +8.13%.
Is MHK a buy, sell or hold?
- StrongBuy: 6
- Buy: 3
- Hold: 9
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MHK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 135.1 | 2.4% |
| Analysts Target Price | 135.1 | 2.4% |
| ValueRay Target Price | 142.5 | 8.1% |
MHK Fundamental Data Overview February 03, 2026
P/E Forward = 12.0627
P/S = 0.6859
P/B = 0.8899
P/EG = 0.9318
Revenue TTM = 10.72b USD
EBIT TTM = 540.7m USD
EBITDA TTM = 1.17b USD
Long Term Debt = 1.74b USD (from longTermDebt, last quarter)
Short Term Debt = 298.2m USD (from shortTermDebt, last quarter)
Debt = 2.34b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.82b USD (from netDebt column, last quarter)
Enterprise Value = 9.18b USD (7.36b + Debt 2.34b - CCE 516.2m)
Interest Coverage Ratio = 20.40 (Ebit TTM 540.7m / Interest Expense TTM 26.5m)
EV/FCF = 15.63x (Enterprise Value 9.18b / FCF TTM 587.2m)
FCF Yield = 6.40% (FCF TTM 587.2m / Enterprise Value 9.18b)
FCF Margin = 5.48% (FCF TTM 587.2m / Revenue TTM 10.72b)
Net Margin = 3.93% (Net Income TTM 421.1m / Revenue TTM 10.72b)
Gross Margin = 24.01% ((Revenue TTM 10.72b - Cost of Revenue TTM 8.15b) / Revenue TTM)
Gross Margin QoQ = 23.74% (prev 25.50%)
Tobins Q-Ratio = 0.67 (Enterprise Value 9.18b / Total Assets 13.62b)
Interest Expense / Debt = 0.21% (Interest Expense 5.00m / Debt 2.34b)
Taxrate = 17.64% (23.3m / 132.1m)
NOPAT = 445.3m (EBIT 540.7m * (1 - 17.64%))
Current Ratio = 2.25 (Total Current Assets 6.01b / Total Current Liabilities 2.67b)
Debt / Equity = 0.28 (Debt 2.34b / totalStockholderEquity, last quarter 8.34b)
Debt / EBITDA = 1.55 (Net Debt 1.82b / EBITDA 1.17b)
Debt / FCF = 3.10 (Net Debt 1.82b / FCF TTM 587.2m)
Total Stockholder Equity = 8.01b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.13% (Net Income 421.1m / Total Assets 13.62b)
RoE = 5.26% (Net Income TTM 421.1m / Total Stockholder Equity 8.01b)
RoCE = 5.54% (EBIT 540.7m / Capital Employed (Equity 8.01b + L.T.Debt 1.74b))
RoIC = 4.37% (NOPAT 445.3m / Invested Capital 10.19b)
WACC = 7.55% (E(7.36b)/V(9.69b) * Re(9.89%) + D(2.34b)/V(9.69b) * Rd(0.21%) * (1-Tc(0.18)))
Discount Rate = 9.89% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.05%
[DCF Debug] Terminal Value 77.75% ; FCFF base≈549.8m ; Y1≈479.7m ; Y5≈386.7m
Fair Price DCF = 94.37 (EV 7.66b - Net Debt 1.82b = Equity 5.83b / Shares 61.8m; r=7.55% [WACC]; 5y FCF grow -15.57% → 2.90% )
EPS Correlation: -50.42 | EPS CAGR: -51.45% | SUE: -4.0 | # QB: 0
Revenue Correlation: -55.24 | Revenue CAGR: -0.03% | SUE: 0.64 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.92 | Chg30d=-0.053 | Revisions Net=-1 | Analysts=17
EPS next Year (2026-12-31): EPS=9.85 | Chg30d=-0.105 | Revisions Net=-3 | Growth EPS=+10.2% | Growth Revenue=+2.2%